Literature DB >> 4988025

Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis.

L J Farrow, E J Holborow, G D Johnson, S G Lamb, J S Stewart, P E Taylor, A J Zuckerman.   

Abstract

In 39 unselected patients with acute infective hepatitis diagnosed on clinical, epidemiological, and pathological findings, smooth muscle (S.M.) antibody was found in 87% and hepatitis-associated antigen in 33%. The incidence of S.M. antibody was highest during the first month after the onset of symptoms, and the antibody was preponderantly IgM at this stage.S.M. antibody and hepatitis-associated antigen occurred independently, and unlike hepatitis-associated antigen, which was strongly associated with possible parenteral exposure to infection, the incidence of S.M. antibody was not related to the presumed mode of exposure. It is concluded that production of S.M. antibody is more directly related to liver cell damage than to the presence of hepatitis-associated antigen in the serum.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4988025      PMCID: PMC1700624          DOI: 10.1136/bmj.2.5711.693

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS.

Authors:  J G WALKER; D DONIACH; I M ROITT; S SHERLOCK
Journal:  Lancet       Date:  1965-04-17       Impact factor: 79.321

Review 2.  Viral hepatitis and the Australia-SH antigen.

Authors:  A J Zuckerman
Journal:  Nature       Date:  1969-08-09       Impact factor: 49.962

Review 3.  A unified concept of autoimmune hepatitis.

Authors:  D Doniach; J G Walker
Journal:  Lancet       Date:  1969-04-19       Impact factor: 79.321

4.  Hepatitis antigen. Correlation with disease and infectivity of blood-donors.

Authors:  D J Gocke; N B Kavey
Journal:  Lancet       Date:  1969-05-31       Impact factor: 79.321

5.  Persistence of the serum hepatitis (SH-Australia) antigen for many years.

Authors:  A J Zuckerman; P E Taylor
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

6.  Relation of Australia-SH antigen to the willowbrook MS-2 strain.

Authors:  J P Giles; R W McCollum; L W Berndtson; S Krugman
Journal:  N Engl J Med       Date:  1969-07-17       Impact factor: 91.245

7.  Failure to detect an antigen associated with hepatitis in a community epidemic.

Authors:  J W Mosley; L F Barker; N R Shulman; M H Hatch
Journal:  Nature       Date:  1970-03-07       Impact factor: 49.962

8.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

9.  Hepatitis and leukemia: their relation to Australia antigen.

Authors:  B S Blumberg; A I Sutnick; W T London
Journal:  Bull N Y Acad Med       Date:  1968-12

10.  Antibody to smooth muscle in patients with liver disease.

Authors:  G D Johnson; E J Holborow; L E Glynn
Journal:  Lancet       Date:  1965-10-30       Impact factor: 79.321

View more
  46 in total

1.  Smooth muscle antibody in patients with warts.

Authors:  S A Mcmillan; M Haire
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

2.  Immunoelectron microscopic evidence of contractile proteins in the cellular and acellular components of mouse kidney glomeruli.

Authors:  L Accinni; P G Natali; L Vassallo; K S Hsu; C De Martino
Journal:  Cell Tissue Res       Date:  1975-10-13       Impact factor: 5.249

3.  Significance of smooth muscle antibodies in liver disease.

Authors:  R M Nakamura
Journal:  Calif Med       Date:  1972-05

4.  Autoantibodies in patients with bronchial carcinoma.

Authors:  M E Hodson; M Turner-Warwick
Journal:  Thorax       Date:  1975-08       Impact factor: 9.139

5.  Smooth-muscle antibodies and other tissue antibodies in cytomegalovirus infection.

Authors:  P Andersen; H K Andersen
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

6.  Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis.

Authors:  K Lidman; G Biberfeld; A Fagraeus; R Norberg; R Torstensson; G Utter; L Carlsson; J Luca; U Lindberg
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

Review 7.  The immunology of liver disorders.

Authors:  G Walker
Journal:  Proc R Soc Med       Date:  1974-06

8.  Paramyxovirus membrane protein augments the antibody response to actin in mice.

Authors:  W T Anomasiri; D L Tyrrell
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

9.  Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpura.

Authors:  F Kanakoudi-Tsakalidis; C Cassimos; T Papastavrou-Mavroudi; T Akoglu; B H Toh; A Yildiz; O Osung; E J Holborow; J Sotelo
Journal:  J Clin Pathol       Date:  1979-12       Impact factor: 3.411

10.  Autoantibodies to intermediate filaments in experimental infections with Trypanosoma brucei gambiense.

Authors:  J A Anthoons; E A Van Marck; P L Gigase
Journal:  Z Parasitenkd       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.